- Home
- CZFS vs TARA Comparison
CZFS vs TARA Comparison
Compare CZFS & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | TARA |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 236.1M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CZFS | TARA |
|---|---|---|
| Price | $83.00 | $3.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $24.40 |
| AVG Volume (30 Days) | 26.1K | ★ 372.7K |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | 30.26 | ★ 38.25 |
| EPS | ★ 4.28 | N/A |
| Revenue | ★ $9,881,000.00 | $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.64 | N/A |
| P/E Ratio | $19.23 | ★ N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $52.35 | $2.97 |
| 52 Week High | $83.37 | $7.82 |
Technical Indicators
Market Signals| Indicator | CZFS | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 42.60 |
| Support Level | $55.53 | $3.72 |
| Resistance Level | $83.37 | $4.23 |
| Average True Range (ATR) | 3.12 | 0.16 |
| MACD | 0.32 | 0.00 |
| Stochastic Oscillator | 90.93 | 31.95 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.